These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15504755)

  • 21. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
    Xu C; Shen G; Chen C; Gélinas C; Kong AN
    Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.
    Grotterød I; Maelandsmo GM; Boye K
    BMC Cancer; 2010 May; 10():241. PubMed ID: 20507646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation.
    Li Y; Sedwick CE; Hu J; Altman A
    J Biol Chem; 2005 Jan; 280(2):1217-23. PubMed ID: 15536066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway.
    Lin ST; Wang Y; Xue Y; Feng DC; Xu Y; Xu LY
    Mol Cell Biochem; 2008 Aug; 315(1-2):41-9. PubMed ID: 18498042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1.
    Marinari B; Costanzo A; Viola A; Michel F; Mangino G; Acuto O; Levrero M; Piccolella E; Tuosto L
    Eur J Immunol; 2002 Feb; 32(2):447-56. PubMed ID: 11813163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis.
    Jin HR; Jin SZ; Cai XF; Li D; Wu X; Nan JX; Lee JJ; Jin X
    PLoS One; 2012; 7(6):e40355. PubMed ID: 22768286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plant alkaloid tetrandrine downregulates protein kinase C-dependent signaling pathway in T cells.
    Ho LJ; Chang DM; Lee TC; Chang ML; Lai JH
    Eur J Pharmacol; 1999 Feb; 367(2-3):389-98. PubMed ID: 10079015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9.
    Takada Y; Aggarwal BB
    J Immunol; 2003 Sep; 171(6):3278-86. PubMed ID: 12960358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
    Sancho R; Macho A; de La Vega L; Calzado MA; Fiebich BL; Appendino G; Muñoz E
    J Immunol; 2004 Feb; 172(4):2341-51. PubMed ID: 14764703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes.
    Molinero LL; Fuertes MB; Girart MV; Fainboim L; Rabinovich GA; Costas MA; Zwirner NW
    J Immunol; 2004 Nov; 173(9):5583-90. PubMed ID: 15494508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
    Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
    J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.
    Manna SK; Mukhopadhyay A; Aggarwal BB
    J Immunol; 2000 Nov; 165(10):5962-9. PubMed ID: 11067959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation.
    Cárcamo JM; Pedraza A; Bórquez-Ojeda O; Golde DW
    Biochemistry; 2002 Oct; 41(43):12995-3002. PubMed ID: 12390026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling.
    Li X; Jin Q; Wu YL; Sun P; Jiang S; Zhang Y; Zhang DQ; Zhang YJ; Lian LH; Nan JX
    Int Immunopharmacol; 2016 Jul; 36():263-270. PubMed ID: 27179306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
    Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
    J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-kappaB activation.
    Feng D; Mei Y; Wang Y; Zhang B; Wang C; Xu L
    Immunol Lett; 2008 Dec; 121(2):127-33. PubMed ID: 18992279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
    Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
    Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways.
    Chen Y; Li H; Li M; Niu S; Wang J; Shao H; Li T; Wang H
    J Ethnopharmacol; 2017 Mar; 200():165-173. PubMed ID: 28232127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.